Marc C Chamberlain. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useAstrocytes/pathologyAstrocytoma/classificationAstrocytoma/pathologyBrain/pathologyBrain Neoplasms/classificationBrain Neoplasms/diagnosisBrain Neoplasms/drug therapyBrain Neoplasms/geneticsBrain Neoplasms/pathologyCell Cycle Proteins/biosynthesisCell Cycle Proteins/geneticsDacarbazine/administration & dosageDacarbazine/analogs & derivativesDisease ProgressionFemaleHumansLomustine/administration & dosageMagnetic Resonance ImagingMaleMiddle AgedNeoplasm InvasivenessNeoplasm Proteins/biosynthesisNeoplasm Proteins/geneticsNeoplasms, Neuroepithelial/classificationNeoplasms, Neuroepithelial/diagnosisNeoplasms, Neuroepithelial/drug therapyNeoplasms, Neuroepithelial/geneticsNeoplasms, Neuroepithelial/pathologyNerve Tissue Proteins/biosynthesisNerve Tissue Proteins/geneticsProcarbazine/administration & dosageTemozolomideVincristine/administration & dosage
Substances: See more » Cell Cycle ProteinsNeoplasm ProteinsNerve Tissue ProteinsProcarbazineVincristineLomustineDacarbazineTemozolomide
Year: 2004 PMID: 15277608 DOI: 10.1212/01.wnl.0000133905.38657.d6
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910